Physician

Anupam Somashekar

According to 2025 Medicare claims, Anupam Somashekar (NPI: 1972036325) practices rheumatology in the Allentown-Bethlehem-Easton, PA-NJ market, with the plurality of this provider's patient population coming from Lehigh, PA. This provider's primary affiliated billing organization is LEHIGH VALLEY PHYSICIAN GROUP (NPI: 1184799694; TIN: 232700908) and primary practice location at 18104-9108. Somashekar is affiliated with the Lehigh Valley Health Network Accountable Care Organization, LLC (ACO ID: A2735), participating under the MSSP model.

Somashekar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 516 traditional Medicare patients, billed 68,939 HCPCS/CPT codes, and received $611,343 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,715 prescription claims across 355 beneficiaries totaling $2,613,383 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 1 records totaling $125. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $5,543 to $2,613,383. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$306K$611K2022 Medicare payment: $24,480 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $482,641 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $611,343 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20221341,325$24,480
202350961,577$482,641
202451668,939$611,343

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.3M$2.6M2017 Drug cost: $5,543 (USD; Tot_Drug_Cst)2018 Drug cost: $12,541 (USD; Tot_Drug_Cst)2019 Drug cost: $16,270 (USD; Tot_Drug_Cst)2020 Drug cost: $73,196 (USD; Tot_Drug_Cst)2021 Drug cost: $399,927 (USD; Tot_Drug_Cst)2022 Drug cost: $489,502 (USD; Tot_Drug_Cst)2023 Drug cost: $1,617,972 (USD; Tot_Drug_Cst)2024 Drug cost: $2,613,383 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R30$5,543
201849203$12,541
201963269$16,270
202096295$73,196
2021115428$399,927
2022154513$489,502
20233331,863$1,617,972
20243552,715$2,613,383

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more216371$66
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more7785$43
J0897Injection, denosumab, 1 mg1228,220$20
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's84109$13
96372Injection of drug or substance under skin or into muscle144187$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab1002,842$783,205
Enbrel SureclickEtanercept28896$230,878
OtezlaApremilast281,078$170,557
RinvoqUpadacitinib27810$167,442
Xeljanz XrTofacitinib Citrate30900$165,987

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$125Aurinia Pharma U.S., Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Anupam Somashekar?

Tedicare shows public-source Medicare data for Anupam Somashekar (NPI 1972036325), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anupam Somashekar have ACO affiliation data?

Anupam Somashekar is shown with ACO affiliation data for Lehigh Valley Health Network Accountable Care Organization, LLC (MSSP, ACO ID A2735).

What billing organization is linked to Anupam Somashekar?

Anupam Somashekar is linked to LEHIGH VALLEY PHYSICIAN GROUP (billing NPI 1184799694) in the available physician profile data.

Does Anupam Somashekar have Open Payments data?

Anupam Somashekar has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.